Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; The Maternal, Infant, and Early Childhood Home Visiting Program Pay for Outcomes Supplemental Information Request, OMB NO. 0906-XXXX NEW, 25873-25875 [2021-09910]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 89 / Tuesday, May 11, 2021 / Notices
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new control number); Title of
Information Collection: The
International Classification of Diseases,
10th Revision, Procedure Coding
System (ICD–10–PCS); Use: The HIPAA
Act of 1996 required CMS to adopt
standards for coding systems that are
used for reporting health care
transactions. The Transactions and Code
Sets final rule (65 FR 50312) published
in the Federal Register on August 17,
2000 adopted the International
Classification of Diseases, 9th Revision,
Clinical Modification (ICD–9–CM)
Volumes 1 and 2 for diagnosis codes
and ICD–9–CM Volume 3 for inpatient
hospital services procedures as standard
code sets for use by covered entities
(health plans, health care
clearinghouses, and those health care
providers who transmit any health
information in electronic form in
connection with a transaction for which
the Secretary has adopted a standard).
The ICD–10–PCS code set has been
maintained, enhanced and expanded as
a direct result of recommendations for
updates (e.g., adding new codes,
deleting codes, and editing descriptive
material related to existing codes)
received from interested stakeholders
from both the public and private sectors.
Thus, information collected in the
application is significant to code set
maintenance. The ICD–10–PCS code set
maintenance is an ongoing process, as
changes are implemented and updated;
therefore, the process requires continual
collection of information from
applicants on a bi-annual basis. As new
technology evolves and new complex
medical procedures are developed,
requests are submitted to CMS
requesting modifications to the ICD–10–
PCS code set. Requests have been
received prior to HIPAA
implementation and must continue to
be collected to facilitate quality
decision-making.
The Committee provides two
meetings each year as a public forum to
discuss proposed changes to ICD–10.
Suggestions to CMS for ICD–10–PCS
procedure code modifications come
from both the public and private sectors.
ICD–10–PCS modification requests can
be proposals for new or revised
procedure codes or requests for
technical coding updates including but
not limited to, enhancements to existing
procedure code concepts, such as
adding a new body part value or a new
approach value. Requestors are asked to
include a description of the procedure
code or change being requested, and
VerDate Sep<11>2014
17:13 May 10, 2021
Jkt 253001
rationale for why the procedure code or
change is needed. Supporting references
and literature may also be submitted.
Interested parties submit these ICD–10–
PCS modification requests three months
prior to a scheduled Spring or Fall C&M
meeting via email to the following email
address: ICDProcedureCodeRequest@
cms.hhs.gov. Form Number: CMS–
10744 (OMB control number: 0938–
New); Frequency: Yearly; Affected
Public: Business or other for-profits and
Not-for-profit institutions and Private
Sector; Number of Respondents: 80;
Total Annual Responses: 80; Total
Annual Hours: 800. (For policy
questions regarding this collection
contact Marilu Hue at 410–786–4510.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Transitional
Pass through payments related to Drugs,
Biologicals, and Radiopharmaceuticals
to determine eligibility under the
Outpatient Prospective Payment
System; Use: Section 201(b) of the
BBRA 1999 amended section 1833(t) of
the Act by adding new section
1833(t)(6). This provision requires the
Secretary to make additional payments
to hospitals for a period of 2 to 3 years
for certain drugs, radiopharmaceuticals,
biological agents, medical devices and
brachytherapy devices. Section
1833(t)(6)(A)(iv) establishes the criteria
for determining the application of this
provision to new items. Section
1833(t)(6)(C)(i) provides that the
additional payment for drugs and
biologicals be the amount by which the
amount determined under section
1842(o) of the Act exceeds the portion
of the otherwise applicable hospital
outpatient department fee schedule
amount that the Secretary determines to
be associated with the drug or
biological.
Interested parties such as hospitals,
pharmaceutical companies, and
physicians will apply for transitional
pass-through payment for drugs,
biologicals, and radiopharmaceuticals
used with services covered under the
hospital OPPS. After we receive all
requested information, we will evaluate
the information to determine if the
criteria for making a transitional passthrough payment are met and if an
interim healthcare common procedure
coding system (HCPCS) code for a new
drug, biological, or radiopharmaceutical
is necessary. We will advise the
applicant of our decision, and update
the hospital OPPS during its next
scheduled quarterly update to reflect
any newly approved drug, biological, or
radiopharmaceutical. We list below the
information that we will require from all
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
25873
applicants. Form Number: CMS–10008
(OMB control number: 0938–0802);
Frequency: Yearly; Affected Public:
Private Sector; Number of Respondents:
30; Total Annual Responses: 30; Total
Annual Hours: 480. (For policy
questions regarding this collection
contact Raymond A. Bulls at 410–7867267.)
Dated: May 5, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–09908 Filed 5–10–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; The Maternal, Infant, and
Early Childhood Home Visiting
Program Pay for Outcomes
Supplemental Information Request,
OMB NO. 0906–XXXX NEW
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted a Supplemental
Information Request (SIR) to the Office
of Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this SIR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this SIR should be
received no later than June 10, 2021.
ADDRESSES: Submit your comments,
including the SIR Title, to the desk
officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by
fax to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
Information Collection Request title for
reference.
SUMMARY:
E:\FR\FM\11MYN1.SGM
11MYN1
25874
Federal Register / Vol. 86, No. 89 / Tuesday, May 11, 2021 / Notices
Information Collection Request Title:
Maternal, Infant, and Early Childhood
Home Visiting Program Pay for
Outcomes Supplemental Information
Request, OMB NO. 0906–XXXX, NEW
Abstract: HRSA is requesting
approval to collect information in
response to a SIR which will include
eligible entities’ plans for
implementation and evaluation of Pay
for Outcomes (PFO) initiatives to be
applied for through the Maternal, Infant,
and Early Childhood Home Visiting
(MIECHV) Program. The Bipartisan
Budget Act of 2018 (Pub. L. 115–123)
added subsection (c)(3) to Section 511 of
the Social Security Act, 42 U.S.C. 711.
The new provision authorizes MIECHV
Program funding recipients to use up to
25 percent of the funds awarded under
subsection 511(c)(1) ‘‘to enable eligible
entities to deliver services under early
childhood home visitation programs’’
for ‘‘outcomes or success payments
related to a pay for outcomes initiative
that will not result in a reduction of
funding for services delivered by the
entity under a childhood home
visitation program under this section
while the eligible entity develops or
operates such an initiative.’’ Subsection
511(j)(3)(B) further requires that ‘‘funds
made available to an eligible entity
under this section for a fiscal year (or
portion of a fiscal year) for a pay for
outcomes initiative shall remain
available for expenditure by the eligible
entity for not more than 10 years after
the funds are so made available.’’
Eligible entities may propose to use
MIECHV funds for outcomes or success
payments related to a PFO initiative in
response to the fiscal year 2021
MIECHV Notice of Funding Opportunity
and in succeeding fiscal years pending
availability of future funds, the recipient
must submit a detailed application that
responds to the forthcoming SIR
(henceforth this application is referred
to as a PFO SIR Response).
A 60-day notice was published in the
Federal Register on July 8, 2020. HRSA
received four comments. Comments
sought clarification on guidance related
to third-party evaluation, selection of
outcome measures, partnership
agreements, budgeting PFO funds,
annual reports, and maintenance of
service delivery. Other comments
highlighted topics that would benefit
from specific technical assistance,
indicated support for various aspects of
the guidance, or offered suggestions that
were outside the intended scope of the
guidance. After taking the public
comments into consideration, HRSA is
proposing final revisions to the PFO SIR
Guidance by making the following
changes:
VerDate Sep<11>2014
17:13 May 10, 2021
Jkt 253001
• Revising the SIR to further describe
expectations and best practices
associated with conducting feasibility
studies and ensuring independence and
accountability in the process. HRSA
will not specify credentials or level of
experience of evaluators or researchers,
allowing recipients to have flexibility to
determine what will work best for their
context.
• Revising the SIR to further clarify
that applicants are to select outcome
measure(s) that will have meaningful
impacts for the children and families
served.
• Editing the SIR to broaden the
requirements around obtaining signed
partnership agreements so that a draft
agreement or letter of intent, as well as
a signed partnership agreement, would
be acceptable.
• Revising the SIR to clarify that
recipients can set aside funds awarded
in multiple years as part of its PFO
initiative. Recipients must propose a
PFO project extending over the project
period of the entire initiative, and must
work closely with HRSA to ensure
appropriate monitoring of use of funds
for this purpose over the 10-year period
of availability.
• Revising the SIR to clarify that the
required annual reports must be made
available to the public and removing
language that may suggest that the
annual reports will include outcomes
that have been achieved and/or
payments made.
• Revising the SIR to clarify the
expectation that recipients must
continue to meet program and model
fidelity requirements with no reduction
of funding for services. HRSA will
further develop and apply criteria as
part of the review and approval process
of any proposed PFO initiatives to
ensure PFO initiatives have no negative
impact on high-quality service delivery.
Need and Proposed Use of the
Information: Congress, through
enactment of the Social Security Act,
Title V, Section 511 (42 U.S.C. 711), as
amended, established the MIECHV
Program. The MIECHV Program is
designed to (1) strengthen and improve
the programs and activities carried out
under Title V of the Social Security Act,
(2) improve coordination of services for
at risk communities, and (3) identify
and provide comprehensive services to
improve outcomes for families who
reside in at risk communities. The
MIECHV Program, authorized by section
511 of the Social Security Act, 42 U.S.C.
711, and administered by HRSA, in
partnership with the Administration for
Children and Families, supports
voluntary, evidence-based home visiting
services during pregnancy and to
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
parents with young children up to
kindergarten entry. States, territories,
tribal entities, and in certain
circumstances, nonprofit organizations
are eligible to receive funding through
MIECHV and have the flexibility, within
the parameters of the authorizing
statute, to tailor the program to serve the
specific needs of their communities.
Section 50605 of the Bipartisan
Budget Act (BBA) of 2018 (Pub. L. 115–
123) added new Section 511(c)(3),
which authorizes MIECHV recipients
the option to use up to 25 percent of
MIECHV funding for ‘‘outcomes or
success payments related to a PFO
initiative that will not result in
reduction of funding for home visiting
services. The new authority establishes
new requirements, including that the
PFO initiative ‘‘will not result in a
reduction of funding for services
delivered by the entity under a
childhood home visitation program
under this section while the eligible
entity develops or operates such an
initiative.’’ Under Section 511(j)(3)(A),
funds used by recipients for a PFO
initiative remain available for
expenditure by the eligible entity for not
more than 10 years after the funds are
made available.
In response to the forthcoming SIR,
MIECHV recipients planning to use
MIECHV grant funds for outcomes or
success payments related to a PFO
initiative will be required to submit a
PFO SIR Response outlining how their
plans will meet all of the applicable
statutory requirements and identifying
what specific MIECHV funds (e.g., fiscal
year 2021 formula funding) they
propose to use to (1) develop and
implement their PFO initiative and (2)
make PFO outcomes or success
payments based on the planned PFO
initiative.
Regarding a PFO initiative, the
MIECHV authorizing statute requires the
following:
(1) A PFO initiative may not result in a
reduction of funding for services delivered by
the entity under a childhood home visitation
program under this section while the eligible
entity develops or operates such an initiative
(section 711(c)(3)); and
(2) The PFO initiative for which outcome
or success payments may be made must
include:
(a) A feasibility study that describes how
the proposed intervention is based on
evidence of effectiveness;
(b) A rigorous, third-party evaluation that
uses experimental or quasi-experimental
design or other research methodologies that
allow for the strongest possible causal
inferences to determine whether the
initiative has met its proposed outcomes as
a result of implementation;
(c) An annual, publicly available report on
the progress of the initiative; and
E:\FR\FM\11MYN1.SGM
11MYN1
25875
Federal Register / Vol. 86, No. 89 / Tuesday, May 11, 2021 / Notices
(d) A requirement that payments are made
to the recipient of the grant, contract, or
cooperative agreement only when agreed
upon outcomes are achieved, excluding
payments made to a third party conducting
the evaluation.
See 42 U.S.C. 711(k)(4).
The forthcoming SIR will provide
further instructions to recipients in
proposing a PFO initiative and
submitting the required information to
HRSA. Recipients are not required to
propose or implement a PFO initiative,
but if they wish to do so, they must
submit a PFO SIR Response describing
how their PFO initiative will meet all of
the applicable statutory requirements.
HRSA will use the information collected
through the PFO SIR Response to ensure
that MIECHV recipients’ proposals to
use grant funds for PFO initiatives meet
statutory requirements and to provide
technical assistance to recipients. The
implementation of a PFO initiative is
not intended to disrupt current services
or negatively impact communities that
have benefited from home visiting
programs and must not result in a
reduction of funding for home visiting
services.
Likely Respondents: MIECHV Program
recipients that are states, territories,
and, where applicable, nonprofit
organizations providing home visiting
services within states.
Number of
respondents
Instrument
Number of
responses per
respondent
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions and
supporting materials; to collect and
analyze data and information to develop
the PFO SIR Response; engage with
stakeholders and coordinate with state
level partners; and to draft and submit
the PFO SIR Response. The table below
summarizes the total annual burden
hours estimated for this SIR.
Total Estimated Annualized Burden
Hours:
Average
burden hours
per response
Total
responses
Total burden
hours
MIECHV PAY FOR OUTCOMES SIR .................................
15
1
15
92
1,380
Total ..............................................................................
15
........................
15
........................
1,380
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–09910 Filed 5–10–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:13 May 10, 2021
Jkt 253001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: May 17, 2021.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fisher Lane, Room 3G45,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Vanitha Sundaresa Raman,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20852, 301–761–7949,
vanitha.raman@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 5, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09913 Filed 5–10–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
131: Mammalian Models for Translational
Research.
Date: June 7, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, (301) 272–
4596, smileyja@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group; Basic
E:\FR\FM\11MYN1.SGM
11MYN1
]]>Agencies
[Federal Register Volume 86, Number 89 (Tuesday, May 11, 2021)]
[Notices]
[Pages 25873-25875]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09910]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; The Maternal, Infant, and
Early Childhood Home Visiting Program Pay for Outcomes Supplemental
Information Request, OMB NO. 0906-XXXX NEW
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted a Supplemental Information Request (SIR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this SIR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this SIR should be received no later than June 10,
2021.
ADDRESSES: Submit your comments, including the SIR Title, to the desk
officer for HRSA, either by email to [email protected] or by
fax to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Lisa Wright-Solomon, the
HRSA Information Collection Clearance Officer at [email protected] or
call (301) 443-1984.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the Information Collection Request title
for reference.
[[Page 25874]]
Information Collection Request Title: Maternal, Infant, and Early
Childhood Home Visiting Program Pay for Outcomes Supplemental
Information Request, OMB NO. 0906-XXXX, NEW
Abstract: HRSA is requesting approval to collect information in
response to a SIR which will include eligible entities' plans for
implementation and evaluation of Pay for Outcomes (PFO) initiatives to
be applied for through the Maternal, Infant, and Early Childhood Home
Visiting (MIECHV) Program. The Bipartisan Budget Act of 2018 (Pub. L.
115-123) added subsection (c)(3) to Section 511 of the Social Security
Act, 42 U.S.C. 711. The new provision authorizes MIECHV Program funding
recipients to use up to 25 percent of the funds awarded under
subsection 511(c)(1) ``to enable eligible entities to deliver services
under early childhood home visitation programs'' for ``outcomes or
success payments related to a pay for outcomes initiative that will not
result in a reduction of funding for services delivered by the entity
under a childhood home visitation program under this section while the
eligible entity develops or operates such an initiative.'' Subsection
511(j)(3)(B) further requires that ``funds made available to an
eligible entity under this section for a fiscal year (or portion of a
fiscal year) for a pay for outcomes initiative shall remain available
for expenditure by the eligible entity for not more than 10 years after
the funds are so made available.''
Eligible entities may propose to use MIECHV funds for outcomes or
success payments related to a PFO initiative in response to the fiscal
year 2021 MIECHV Notice of Funding Opportunity and in succeeding fiscal
years pending availability of future funds, the recipient must submit a
detailed application that responds to the forthcoming SIR (henceforth
this application is referred to as a PFO SIR Response).
A 60-day notice was published in the Federal Register on July 8,
2020. HRSA received four comments. Comments sought clarification on
guidance related to third-party evaluation, selection of outcome
measures, partnership agreements, budgeting PFO funds, annual reports,
and maintenance of service delivery. Other comments highlighted topics
that would benefit from specific technical assistance, indicated
support for various aspects of the guidance, or offered suggestions
that were outside the intended scope of the guidance. After taking the
public comments into consideration, HRSA is proposing final revisions
to the PFO SIR Guidance by making the following changes:
Revising the SIR to further describe expectations and best
practices associated with conducting feasibility studies and ensuring
independence and accountability in the process. HRSA will not specify
credentials or level of experience of evaluators or researchers,
allowing recipients to have flexibility to determine what will work
best for their context.
Revising the SIR to further clarify that applicants are to
select outcome measure(s) that will have meaningful impacts for the
children and families served.
Editing the SIR to broaden the requirements around
obtaining signed partnership agreements so that a draft agreement or
letter of intent, as well as a signed partnership agreement, would be
acceptable.
Revising the SIR to clarify that recipients can set aside
funds awarded in multiple years as part of its PFO initiative.
Recipients must propose a PFO project extending over the project period
of the entire initiative, and must work closely with HRSA to ensure
appropriate monitoring of use of funds for this purpose over the 10-
year period of availability.
Revising the SIR to clarify that the required annual
reports must be made available to the public and removing language that
may suggest that the annual reports will include outcomes that have
been achieved and/or payments made.
Revising the SIR to clarify the expectation that
recipients must continue to meet program and model fidelity
requirements with no reduction of funding for services. HRSA will
further develop and apply criteria as part of the review and approval
process of any proposed PFO initiatives to ensure PFO initiatives have
no negative impact on high-quality service delivery.
Need and Proposed Use of the Information: Congress, through
enactment of the Social Security Act, Title V, Section 511 (42 U.S.C.
711), as amended, established the MIECHV Program. The MIECHV Program is
designed to (1) strengthen and improve the programs and activities
carried out under Title V of the Social Security Act, (2) improve
coordination of services for at risk communities, and (3) identify and
provide comprehensive services to improve outcomes for families who
reside in at risk communities. The MIECHV Program, authorized by
section 511 of the Social Security Act, 42 U.S.C. 711, and administered
by HRSA, in partnership with the Administration for Children and
Families, supports voluntary, evidence-based home visiting services
during pregnancy and to parents with young children up to kindergarten
entry. States, territories, tribal entities, and in certain
circumstances, nonprofit organizations are eligible to receive funding
through MIECHV and have the flexibility, within the parameters of the
authorizing statute, to tailor the program to serve the specific needs
of their communities.
Section 50605 of the Bipartisan Budget Act (BBA) of 2018 (Pub. L.
115-123) added new Section 511(c)(3), which authorizes MIECHV
recipients the option to use up to 25 percent of MIECHV funding for
``outcomes or success payments related to a PFO initiative that will
not result in reduction of funding for home visiting services. The new
authority establishes new requirements, including that the PFO
initiative ``will not result in a reduction of funding for services
delivered by the entity under a childhood home visitation program under
this section while the eligible entity develops or operates such an
initiative.'' Under Section 511(j)(3)(A), funds used by recipients for
a PFO initiative remain available for expenditure by the eligible
entity for not more than 10 years after the funds are made available.
In response to the forthcoming SIR, MIECHV recipients planning to
use MIECHV grant funds for outcomes or success payments related to a
PFO initiative will be required to submit a PFO SIR Response outlining
how their plans will meet all of the applicable statutory requirements
and identifying what specific MIECHV funds (e.g., fiscal year 2021
formula funding) they propose to use to (1) develop and implement their
PFO initiative and (2) make PFO outcomes or success payments based on
the planned PFO initiative.
Regarding a PFO initiative, the MIECHV authorizing statute requires
the following:
(1) A PFO initiative may not result in a reduction of funding
for services delivered by the entity under a childhood home
visitation program under this section while the eligible entity
develops or operates such an initiative (section 711(c)(3)); and
(2) The PFO initiative for which outcome or success payments may
be made must include:
(a) A feasibility study that describes how the proposed
intervention is based on evidence of effectiveness;
(b) A rigorous, third-party evaluation that uses experimental or
quasi-experimental design or other research methodologies that allow
for the strongest possible causal inferences to determine whether
the initiative has met its proposed outcomes as a result of
implementation;
(c) An annual, publicly available report on the progress of the
initiative; and
[[Page 25875]]
(d) A requirement that payments are made to the recipient of the
grant, contract, or cooperative agreement only when agreed upon
outcomes are achieved, excluding payments made to a third party
conducting the evaluation.
See 42 U.S.C. 711(k)(4).
The forthcoming SIR will provide further instructions to recipients
in proposing a PFO initiative and submitting the required information
to HRSA. Recipients are not required to propose or implement a PFO
initiative, but if they wish to do so, they must submit a PFO SIR
Response describing how their PFO initiative will meet all of the
applicable statutory requirements. HRSA will use the information
collected through the PFO SIR Response to ensure that MIECHV
recipients' proposals to use grant funds for PFO initiatives meet
statutory requirements and to provide technical assistance to
recipients. The implementation of a PFO initiative is not intended to
disrupt current services or negatively impact communities that have
benefited from home visiting programs and must not result in a
reduction of funding for home visiting services.
Likely Respondents: MIECHV Program recipients that are states,
territories, and, where applicable, nonprofit organizations providing
home visiting services within states.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions and supporting materials; to collect and analyze data and
information to develop the PFO SIR Response; engage with stakeholders
and coordinate with state level partners; and to draft and submit the
PFO SIR Response. The table below summarizes the total annual burden
hours estimated for this SIR.
Total Estimated Annualized Burden Hours:
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per Total burden hours Total burden
respondents respondent responses per response hours
----------------------------------------------------------------------------------------------------------------
MIECHV PAY FOR OUTCOMES SIR..... 15 1 15 92 1,380
-------------------------------------------------------------------------------
Total....................... 15 .............. 15 .............. 1,380
----------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-09910 Filed 5-10-21; 8:45 am]
BILLING CODE 4165-15-P
